|
Market Closed -
Toronto S.E.
09:30:00 2026-09-25 EDT
|
5-day change | 1st Jan Change | ||
| 0.0550 CAD | -15.38% |
|
-21.43% | -38.89% |
Company Valuation: Hemostemix Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 32.46 | 9.464 | 13.63 | 6.099 | 17 | 17.57 |
| Change | - | -70.84% | 44.06% | -55.27% | 178.71% | 3.39% |
| Enterprise Value (EV) 1 | 32.38 | 10.73 | 17.62 | 10.26 | 21.23 | 20.43 |
| Change | - | -66.87% | 64.3% | -41.76% | 106.81% | -3.74% |
| P/E | -2.91x | -1.46x | -2.41x | -2.31x | -4.36x | -3.12x |
| PBR | -35.4x | -1.79x | -2.01x | -0.83x | -2.34x | -3.53x |
| PEG | - | 0x | 0.1x | 0x | 0.47x | -0.65x |
| Capitalization / Revenue | - | - | - | - | - | - |
| EV / Revenue | - | - | - | - | - | - |
| EV / EBITDA | -6.64x | -1.61x | -5.38x | -4.4x | -11.1x | -3.88x |
| EV / EBIT | -6.64x | -1.61x | -5.38x | -4.4x | -11.1x | -3.88x |
| EV / FCF | -20x | -10.5x | -4.62x | -8.35x | -14.3x | -6.18x |
| FCF Yield | -5.01% | -9.48% | -21.7% | -12% | -6.97% | -16.2% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.241 | -0.1094 | -0.0748 | -0.0303 | -0.0275 | -0.0288 |
| Distribution rate | - | - | - | - | - | - |
| Net sales | - | - | - | - | - | - |
| EBITDA 1 | -4.876 | -6.655 | -3.273 | -2.333 | -1.912 | -5.266 |
| EBIT 1 | -4.879 | -6.656 | -3.274 | -2.334 | -1.912 | -5.266 |
| Net income 1 | -7.768 | -6.286 | -5.235 | -2.502 | -2.616 | -4.714 |
| Net Debt 1 | -0.083 | 1.262 | 3.99 | 4.166 | 4.231 | 2.861 |
| Reference price 2 | 0.7000 | 0.1600 | 0.1800 | 0.0700 | 0.1200 | 0.0900 |
| Nbr of stocks (in thousands) | 46,369 | 59,151 | 75,743 | 87,122 | 141,642 | 195,253 |
| Announcement Date | 4/30/21 | 5/3/22 | 5/1/23 | 4/29/24 | 4/29/25 | 5/1/26 |
1CAD in Million2CAD
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 8.23M | |
| 21.09x | 7.5x | 15.07x | 1.41% | 72.26B | |
| 31.3x | 9.02x | 28.11x | 0.04% | 60.24B | |
| 32.1x | 6.85x | 17.78x | -.--% | 27.73B | |
| -72.3x | 13.87x | -75.56x | -.--% | 25.74B | |
| -15.17x | 5.73x | -7.2x | -.--% | 24.75B | |
| 28.46x | 5.35x | 17.81x | -.--% | 20.74B | |
| 42.74x | 15.97x | 32.4x | 0.35% | 15.06B | |
| 17.96x | 5.35x | 12.5x | -.--% | 14.42B | |
| 1015.79x | 35.53x | 613.78x | -.--% | 14.23B | |
| Average | 122.44x | 11.69x | 72.74x | 0.2% | 27.52B | |
| Weighted average by Cap. | 65.45x | 9.84x | 39.70x | 0.4% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- HEM Stock
- Valuation Hemostemix Inc.
Select your edition
All financial news and data tailored to specific country editions
